Searched for
TECENTRIQ
Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...- Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancerRoche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...
- Jazz Pharma, Roche's combination therapy for lung cancer gets US approvalThe FDA has approved Jazz Pharmaceuticals' Zepzelca and Roche's Tecentriq combination as the first and only first-line maintenance treatmen...
- India clears Roche’s 7-minute cancer injection Tecentriq for patients, with Phase IV trial conditionRoche has received clearance to import and market Atezolizumab injection (Tecentriq) for subcutaneous administration in India, potentially ...
- England to rollout world's first seven-minute cancer treatment injectionAtezolizumab - made by Genentech, a Roche company - is an immunotherapy drug that empowers a patient's own immune system to seek and destro...
- Blow to Roche's cancer immunotherapy prospects as 2nd trial failsIn a study, a combination of tiragolumab and Roche's established Tecentriq drug did not slow disease progression in newly diagnosed cases o...
- Roche India head Lara Bezerra set to exitA Roche India spokesperson confirmed the development and said an announcement for a new India head will be made soon. “Dec. 1 will be the d...
- World Cancer Day: Immunotherapy can help patients suffering from carcinoma of the lungsImmunotherapy should be given as early as possible to achieve a lasting remission of the disease.
Load More